Cargando…

The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?

BACKGROUND: The purpose of the present correlative immunohistochemical study was to assess the utility of cytokeratin (CK7 and CK20) expression in the diagnosis of short-segment Barrett esophagus, particularly its efficacy in differentiating Barrett mucosa from intestinal metaplasia of the gastric c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurtkaya-Yapicier, Ozlem, Gencosmanoglu, Rasim, Avsar, Erol, Bakirci, Nadi, Tozun, Nurdan, Sav, Aydin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC305372/
https://www.ncbi.nlm.nih.gov/pubmed/14651756
http://dx.doi.org/10.1186/1472-6890-3-5
_version_ 1782121105038770176
author Kurtkaya-Yapicier, Ozlem
Gencosmanoglu, Rasim
Avsar, Erol
Bakirci, Nadi
Tozun, Nurdan
Sav, Aydin
author_facet Kurtkaya-Yapicier, Ozlem
Gencosmanoglu, Rasim
Avsar, Erol
Bakirci, Nadi
Tozun, Nurdan
Sav, Aydin
author_sort Kurtkaya-Yapicier, Ozlem
collection PubMed
description BACKGROUND: The purpose of the present correlative immunohistochemical study was to assess the utility of cytokeratin (CK7 and CK20) expression in the diagnosis of short-segment Barrett esophagus, particularly its efficacy in differentiating Barrett mucosa from intestinal metaplasia of the gastric cardia and corpus. METHODS: Two groups of endoscopic biopsy specimens were examined, including 20 endoscopic biopsy specimens of short-segment Barrett esophagus (Group A) and equal number exhibiting Helicobacter pylori associated intestinal metaplasia of the gastric cardia and corpus (Group B). All were investigated by immunohistochemistry using the standard ABC method for CK7 and CK20 expression. Fisher's exact test was used for statistical analysis of Barrett CK7/20 and gastric CK7/20 patterns between the groups. RESULTS: The anticipated pattern of reactivity in Barrett mucosa (CK7: strong diffuse positivity in superficial and deep glands; CK20: positivity in surface epithelium and superficial glands) was seen in 2 cases of Group A specimens. The expected gastric pattern (CK7: patchy immunostaining with variable involvement of deep glands; CK20: patchy immunostaining of superficial and deep glands in incomplete intestinal metaplasia / absence of CK7 immunoreactivity with strong CK20 staining in superficial and deep glands in complete intestinal metaplasia) was seen in 8 cases of Group B specimens. The respective sensitivity and false-negativity values of CK7/20 staining for Barrett pattern in Group A were 10% and 90%, respectively. These values for gastric pattern in Group B were 40% and 60%, respectively. The specificity and false-positivity values of both patterns were same (100% and 0%, respectively). There was no statistically significant difference for Barrett pattern between the two groups (P = 0.487), while the observation of gastric pattern was significantly higher in Group B than in Group A (P = 0.02). CONCLUSIONS: We concluded that these hypothesized and recently applied diagnostic criteria involving CK7 and CK20 immunoreactivity are not reliable in distinguishing short-segment Barrett esophagus from intestinal metaplasia as seen in gastric cardia and corpus.
format Text
id pubmed-305372
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-3053722004-01-01 The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable? Kurtkaya-Yapicier, Ozlem Gencosmanoglu, Rasim Avsar, Erol Bakirci, Nadi Tozun, Nurdan Sav, Aydin BMC Clin Pathol Research Article BACKGROUND: The purpose of the present correlative immunohistochemical study was to assess the utility of cytokeratin (CK7 and CK20) expression in the diagnosis of short-segment Barrett esophagus, particularly its efficacy in differentiating Barrett mucosa from intestinal metaplasia of the gastric cardia and corpus. METHODS: Two groups of endoscopic biopsy specimens were examined, including 20 endoscopic biopsy specimens of short-segment Barrett esophagus (Group A) and equal number exhibiting Helicobacter pylori associated intestinal metaplasia of the gastric cardia and corpus (Group B). All were investigated by immunohistochemistry using the standard ABC method for CK7 and CK20 expression. Fisher's exact test was used for statistical analysis of Barrett CK7/20 and gastric CK7/20 patterns between the groups. RESULTS: The anticipated pattern of reactivity in Barrett mucosa (CK7: strong diffuse positivity in superficial and deep glands; CK20: positivity in surface epithelium and superficial glands) was seen in 2 cases of Group A specimens. The expected gastric pattern (CK7: patchy immunostaining with variable involvement of deep glands; CK20: patchy immunostaining of superficial and deep glands in incomplete intestinal metaplasia / absence of CK7 immunoreactivity with strong CK20 staining in superficial and deep glands in complete intestinal metaplasia) was seen in 8 cases of Group B specimens. The respective sensitivity and false-negativity values of CK7/20 staining for Barrett pattern in Group A were 10% and 90%, respectively. These values for gastric pattern in Group B were 40% and 60%, respectively. The specificity and false-positivity values of both patterns were same (100% and 0%, respectively). There was no statistically significant difference for Barrett pattern between the two groups (P = 0.487), while the observation of gastric pattern was significantly higher in Group B than in Group A (P = 0.02). CONCLUSIONS: We concluded that these hypothesized and recently applied diagnostic criteria involving CK7 and CK20 immunoreactivity are not reliable in distinguishing short-segment Barrett esophagus from intestinal metaplasia as seen in gastric cardia and corpus. BioMed Central 2003-12-02 /pmc/articles/PMC305372/ /pubmed/14651756 http://dx.doi.org/10.1186/1472-6890-3-5 Text en Copyright © 2003 Kurtkaya-Yapicier et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research Article
Kurtkaya-Yapicier, Ozlem
Gencosmanoglu, Rasim
Avsar, Erol
Bakirci, Nadi
Tozun, Nurdan
Sav, Aydin
The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?
title The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?
title_full The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?
title_fullStr The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?
title_full_unstemmed The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?
title_short The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?
title_sort utility of cytokeratins 7 and 20 (ck7/20) immunohistochemistry in the distinction of short-segment barrett esophagus from gastric intestinal metaplasia: is it reliable?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC305372/
https://www.ncbi.nlm.nih.gov/pubmed/14651756
http://dx.doi.org/10.1186/1472-6890-3-5
work_keys_str_mv AT kurtkayayapicierozlem theutilityofcytokeratins7and20ck720immunohistochemistryinthedistinctionofshortsegmentbarrettesophagusfromgastricintestinalmetaplasiaisitreliable
AT gencosmanoglurasim theutilityofcytokeratins7and20ck720immunohistochemistryinthedistinctionofshortsegmentbarrettesophagusfromgastricintestinalmetaplasiaisitreliable
AT avsarerol theutilityofcytokeratins7and20ck720immunohistochemistryinthedistinctionofshortsegmentbarrettesophagusfromgastricintestinalmetaplasiaisitreliable
AT bakircinadi theutilityofcytokeratins7and20ck720immunohistochemistryinthedistinctionofshortsegmentbarrettesophagusfromgastricintestinalmetaplasiaisitreliable
AT tozunnurdan theutilityofcytokeratins7and20ck720immunohistochemistryinthedistinctionofshortsegmentbarrettesophagusfromgastricintestinalmetaplasiaisitreliable
AT savaydin theutilityofcytokeratins7and20ck720immunohistochemistryinthedistinctionofshortsegmentbarrettesophagusfromgastricintestinalmetaplasiaisitreliable
AT kurtkayayapicierozlem utilityofcytokeratins7and20ck720immunohistochemistryinthedistinctionofshortsegmentbarrettesophagusfromgastricintestinalmetaplasiaisitreliable
AT gencosmanoglurasim utilityofcytokeratins7and20ck720immunohistochemistryinthedistinctionofshortsegmentbarrettesophagusfromgastricintestinalmetaplasiaisitreliable
AT avsarerol utilityofcytokeratins7and20ck720immunohistochemistryinthedistinctionofshortsegmentbarrettesophagusfromgastricintestinalmetaplasiaisitreliable
AT bakircinadi utilityofcytokeratins7and20ck720immunohistochemistryinthedistinctionofshortsegmentbarrettesophagusfromgastricintestinalmetaplasiaisitreliable
AT tozunnurdan utilityofcytokeratins7and20ck720immunohistochemistryinthedistinctionofshortsegmentbarrettesophagusfromgastricintestinalmetaplasiaisitreliable
AT savaydin utilityofcytokeratins7and20ck720immunohistochemistryinthedistinctionofshortsegmentbarrettesophagusfromgastricintestinalmetaplasiaisitreliable